LEVODOPA/CARBIDOPA/ENTACAPONE ORION
200MG/50MG/200MG TBL FLM 130
| SÚKL code | 0168719 |
|---|---|
| Name of the product | LEVODOPA/CARBIDOPA/ENTACAPONE ORION |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | LEVODOPA/CARBIDOPA/ENTACAPONE ORION |
| Supplement | 200MG/50MG/200MG TBL FLM 130 |
| Strenght | 200MG/50MG/200MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 130 |
| Route | Oral use |
| Wrap type | Tablet container |
| Legal status | na lékařský předpis |
| Active substance |
LEVODOPA (LEVODOPUM) CARBIDOPA (CARBIDOPUM) ENTACAPONE (ENTACAPONUM) |
| ATC group | N04BA03 |
| ATC group name | LEVODOPA, INHIBITOR DEKARBOXYLASY A INHIBITOR COMT |
Marketing authorisation information
| Registration Number | EU/1/11/706/032 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Orion Corporation, Espoo |
| MA Holder country | FINSKO |
cz